1. DNA-lesion mapping in mammalian cells.
- Author
-
Besaratinia A and Pfeifer GP
- Subjects
- Animals, Base Pairing, Base Sequence, Carcinogens toxicity, Cell Transformation, Neoplastic chemically induced, Cell Transformation, Neoplastic genetics, DNA genetics, DNA Adducts analysis, DNA Mutational Analysis, DNA Primers, Genes, p53, Genome, Human, Humans, Mammals, Mutagenesis, Mutation drug effects, Nucleic Acid Amplification Techniques, Pyrimidine Dimers radiation effects, Reproducibility of Results, Sensitivity and Specificity, Sequence Analysis, DNA, Templates, Genetic, Ultraviolet Rays, Cells, DNA Damage, DNA Footprinting methods, DNA Ligases metabolism, Polymerase Chain Reaction methods
- Abstract
Formation of DNA damage is a crucial event in carcinogenesis. Irreparable DNA lesions have the potential to cause mispairing during DNA replication, thereby giving rise to mutations. Critically important mutations in cancer-related genes, i.e., oncogenes and tumor suppressor genes, are key contributors to carcinogenesis. Theoretically, co-localization(s) of persistent DNA lesions and mutational hotspots in cancer-relevant genes can be used for causality inference. The inferred causality can be validated if a suspected carcinogen can similarly produce corresponding patterns of DNA damage and mutagenesis in vitro and/or in vivo. DNA-lesion footprinting (mapping) in conjunction with mutagenicity analysis is used for investigating cancer etiology. Ligation-mediated polymerase chain reaction (LM-PCR) is a versatile DNA-lesion footprinting technique, which enables sensitive and specific detection of DNA damage, at the level of nucleotide resolution, in genomic DNA. Here, we describe an updated protocol for LM-PCR analysis of the mammalian genome. This protocol can routinely be used for DNA-lesion footprinting of a variety of chemical and/or physical carcinogens in mammalian cells.
- Published
- 2009
- Full Text
- View/download PDF